Solazyme Inc  

(Public, NASDAQ:SZYM)   Watch this stock  
Find more results for solazyme
9.04
-0.19 (-2.06%)
Aug 28 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 9.03 - 9.27
52 week 8.00 - 15.00
Open 9.18
Vol / Avg. 550,885.00/779,090.00
Mkt cap 726.38M
P/E     -
Div/yield     -
EPS -2.03
Shares 78.70M
Beta 1.71
Inst. own 67%
Nov 3, 2014
Q3 2014 Solazyme Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Aug 12, 2014
Solazyme Inc at Pacific Crest Global Technology Leadership Forum
Aug 11, 2014
Solazyme Inc at Jefferies Global Industrials Conference
Jul 30, 2014
Q2 2014 Solazyme Inc Earnings Call
Jul 30, 2014
Q2 2014 Solazyme Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin -269.26% -292.80%
Operating margin -202.22% -241.86%
EBITD margin - -229.01%
Return on average assets -54.28% -48.93%
Return on average equity -120.25% -72.23%
Employees 271 -
CDP Score - -

Address

225 GATEWAY BLVD.
SOUTH SAN FRANCISCO, CA 94080
United States - Map
+1-650-7804777 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Solazyme, Inc. (Solazyme) makes oil. The Company�s technology transforms a range of plant-based sugars into oils. Its renewable products can replace or enhance oils derived from the world�s three existing sources-petroleum, plants and animal fats. The Company is focused on commercializing its products into three target markets: fuels and chemicals, nutrition, and skin and personal care. In 2010, the Company launched its products, the Golden Chlorella line of dietary supplements. In March 2011, the Company launched its Algenist brand for the luxury skin care market through marketing and distribution arrangements with Sephora S.A. (Sephora International), Sephora USA, Inc. (Sephora USA), and QVC, Inc. (QVC).

Officers and directors

Jerry L. Fiddler Independent Chairman of the Board
Age: 62
Bio & Compensation  - Reuters
David C. Cole President, Director
Age: 61
Bio & Compensation  - Reuters
Jonathan S. Wolfson JD Chief Executive Officer, Director
Age: 43
Bio & Compensation  - Reuters
Tyler W. Painter Chief Financial Officer, Chief Operating Officer
Age: 42
Bio & Compensation  - Reuters
Peter J. Licari Ph.D. Chief Technology Officer
Age: 50
Bio & Compensation  - Reuters
Paul T. Quinlan General Counsel, Corporate Secretary
Age: 51
Bio & Compensation  - Reuters
James R. Craigie Director
Age: 60
Bio & Compensation  - Reuters
Peter Kovacs Director
Age: 72
Bio & Compensation  - Reuters
Michael V. Arbige Ph.D. Independent Director
Age: 60
Bio & Compensation  - Reuters
Ian T. Clark Independent Director
Age: 53
Bio & Compensation  - Reuters